One candidate gene (S100A2) has previously been nominated from RNA sequencing data as a downstream partner of three fusion transcripts in the CRC cell line RKO, with ZNF833, RP1–28O10.1, and AMPD3 as 5′ fusion partners [25]. This evidence concerns the gene RP1 and colorectal carcinoma.